Application of in vivo microdialysis for studying the efficacy of protective preparations against sulfur mustard penetrating the skin.

Subcutaneous microdialysis was employed for monitoring thiodiglycol (2,2'-thiodiethanol, TDG) levels with the aim of characterizing the transdermal penetration of topically applied liquid sulfur mustard (2,2'-dichlorodiethyl sulfide, SM) in rats. TDG levels, evaluated in 20 min dialysates collected over a 6 h sampling period, were plotted against time after pooling. Linear correlation was identified between the SM dose and the mean areas under the 0-60 min or the whole curve (AUC(0-60) and AUC, respectively) as well as mean peak concentrations (C(max)) in the range of 1.0-3.0 microl applied volume (7.2-21.7 nmol).A commercially available barrier cream, a perfluoropolyether oil and a vaseline based ointment containing zinc oxide were subsequently tested as topical protectants. Each preparation was layered on the skin surface prior to the application of 2.0 microl SM. The evaluation of the efficacy of the preparations was based on obtained AUC(0-60), AUC and C(max) values. A statistical comparison of these parameters with those obtained when 2.0 microl SM was applied without pretreatment indicated that the barrier cream and the perfluoropolyether oil significantly (P < 0.01) reduced the amount of penetrating SM within the sampling period. In addition, the perfluoropolyether oil almost completely prevented the penetration of SM for 20 min. Pretreatment with the ointment did not prove to be an effective countermeasure as its administration resulted in no significant reduction in AUC(0-60), AUC and C(max) values.

Quantitative analysis of the sulfur mustard hydrolysis product thiodiglycol (2,2'-sulfobisethanol) in in vivo microdialysates using gas chromatography coupled with pulsed flame photometric detection.

An analytical method employing gas chromatography is presented for assessing the concentrations of the sulfur mustard hydrolysis product thiodiglycol (TDG) in cutaneous in vivo microdialysates. The use of a pulsed flame photometric detector allows for selective detection of the analyte following solvent exchange and derivatization with heptafluorobutyric anhydride. Quantitative assessment is performed using thiodipropanol (TDP) as a surrogate internal standard. A linear relationship and a very significant correlation (r2 = 0.9982) between the ratio of TDG and TDP concentrations and the ratio of the square root of peak heights is demonstrated. The suitability of the analytical method is verified by the evaluation of blank in vivo microdialysates spiked with known amounts of TDG. The limit of detection in microdialysates is 0.200 nmol/mL (24.4 ng/mL) and the limit of quantitation was 0.364 nmol/mL (44.4 ng/mL). The presented method provides selective, sensitive, rapid, and high-throughput analysis of microdialysates containing TDG, providing an efficient alternative for high-performance liquid chromatography and capillary electrophoresis techniques.

Mass selective detection of amphetamine, methamphetamine, and related compounds in urine.

A method is presented for the routine analysis of amphetamine, methamphetamine, and related compounds in urine with gas chromatography coupled with mass spectrometry operated in the selective ion monitoring mode. The analytes are isolated by liquid-liquid extraction and are derivatized with trifluoroacetic anhydride. 3,4-Methylenedioxy-methamphetamine-D(5) is employed as the internal standard. Standard solutions are prepared using spiked urine samples, which are subjected to all phases of sample preparation. Disposable deactivated glass containers are employed throughout the process.

Gas chromatography-mass spectrometry-single ion monitoring measurement of 11-nor-delta 9-tetrahydrocannabinol-carboxylic acid in urine.

Gas chromatography combined with mass spectrometry is used to determine the urinary elimination of 11-nor-Delta(9)-tetrahydrocannabinol-carboxylic acid. Single ion monitoring of both 11-nor-Delta(9)-tetrahydrocannabinol-carboxylic acid and the internal standard (11-nor-Delta(9)-tetrahydrocannabinol-carboxylic-D9) offers selective and sensitive measurement. In order to check the method and the results, we employ 11-nor-Delta(9)-tetrahydrocannabinol-carboxylic acid-glucuronide as an external standard. Our study also demonstrates that the wall of the glass liner (glass tube) in the injector retards the active compound, which makes it imperative to replace the glass insert after each run. Otherwise, the value of the drug measured in subsequent runs will decrease because more of this compound will adhere to the glass walls.

Effect of mixed ligand complex therapy on the retention of 95Nb and 144Ce in mice.

We have examined in mice the effects of mixed ligand treatments with desferrioxamine B (DFOA), Na3Ca-diethylenetriamine pentaacetic acid (DTPA), and DL-penicillamine (PA) on the retention of a mixture of 95Nb and 144Ce. The results show that 95Nb + 144Ce could be mobilized effectively by simultaneous application of specific agents (i.e., DFOA, DTPA) with no decrease in their efficiencies.

Effect of 60Co-Gamma whole body irradiation and treatment with radioprotector on the retention of 144Ce, in mice.

In animal experiments the effects of 7.5 Gy whole-body irradiation (LD50/30) and/or of radioprotecting compound (WR-2721) on the retention and elimination of 144Ce were investigated. It was stated that in the first three days there was an increase in the deposition of 144Ce after whole-body irradiation and upon treatment with radioprotective compound WR-2721.

Influence of mixed-ligand complexes on retention and distribution of radioniobium in mice.

The individual effects of desferrioxamine B (DFOA), Na3Ca diethylenetriaminepentaacetic acid (DTPA), Na-salicylate, DL-penicillamine, and 2-aminoethylisothiouronium bromide hydrobromide, as well as the effect of mixed-ligand treatment on the retention and elimination of 95Nb in mice have been examined. It was found that 95Nb could easily be mobilized by a single dose of DFOA, but the best result was obtained with the DFOA and DTPA combination. Mixed-ligand treatment did not change the deposition characteristics and translocation kinetics of 95Nb.

Modification of 144Ce tissue deposition by mixed ligand complex treatment in mice.

The individual effect of desferrioxamine-B (DFOA), Na3Ca-diethylene-triaminepentaacetic acid (DTPA), DL-penicillamine (PA) and Na-salicylate (SA) has been examined as well as the effect of mixed-ligand treatment on the retention and elimination of 144Ce in mice. It was found that 144Ce could easily be mobilized by a single dose of DTPA. Mixed-ligand (MLCs) treatment did not change the deposition characteristics and translocation kinetics of 144Ce.